cross linking dogs_cats_famose_ecvo

26
* EVALUATION OF ACCELERATED-CXL FOR THE TREATMENT OF MELTING KERATITIS IN 8 DOGS AND 10 CATS * Collagen Cross-Linking Dr Frank FAMOSE – Toulouse - France [email protected] Barcelona 2013

Upload: frank-famose

Post on 08-Jul-2015

215 views

Category:

Health & Medicine


2 download

TRANSCRIPT

Page 1: Cross linking dogs_cats_famose_ecvo

* EVALUATION OF ACCELERATED-CXL FOR THE TREATMENT OF MELTING KERATITIS IN 8 DOGS AND 10 CATS

* Collagen Cross-Linking

Dr Frank FAMOSE – Toulouse - [email protected] 2013

Page 2: Cross linking dogs_cats_famose_ecvo

Melting keratitis

MMP imbalance

Infectious and non-infectious origin

Treatment : antibiotics& anticollagenases

Evolution : perforation

Surgery

Page 3: Cross linking dogs_cats_famose_ecvo

Collagen reticulation

Anti-infectious effects

Keratocyte apoptosis

Photochemicalprocess

CXL

Page 4: Cross linking dogs_cats_famose_ecvo

Background

StandardProtocol30min 3mW/cm²

Page 5: Cross linking dogs_cats_famose_ecvo

Aim of this study

Page 6: Cross linking dogs_cats_famose_ecvo

Inclusion criteria

Dogs and cats

Corneal melting

Poor response to medical treatment

Page 7: Cross linking dogs_cats_famose_ecvo

Inclusion criteria

Epithelial loss

Cellular infiltration andstromal dissolution

Minimal Corneal thickness> 300 µm

Page 8: Cross linking dogs_cats_famose_ecvo

Protocol

Generalanesthesia

Cornealcleaning

Riboflavinesoaking

ExpositionUVA 365 nm

Post-CXLtreatment

OCT

MedetomidineKetamineIsoflurane

Debris removalBact. sampling

PCR (FHV1)

RF 0,1% 20% dextran(VibexTM)

1 drop ev. 2 min30 minutes

30 mW/cm�3 min

5,4J/cm�

TobrexTM BID7 days

Accelerated protocol(KXLTM – Avedro)

Page 9: Cross linking dogs_cats_famose_ecvo

Follow-up

Inclusion D4 D8 D15 D31

Pain and clinical score

Fluorescein test

Page 10: Cross linking dogs_cats_famose_ecvo

Follow-up

0 : absent1 : light2 : moderate3 : severe

0 : absent1 : present

Page 11: Cross linking dogs_cats_famose_ecvo

Results

Pretreatment data

Page 12: Cross linking dogs_cats_famose_ecvo

Results

8 Dogs 10 Cats

Page 13: Cross linking dogs_cats_famose_ecvo

Corneal infiltration

D1 D8

8/8 dogs – 10/10 cats 0/8 dogs – 0/10 cats

Page 14: Cross linking dogs_cats_famose_ecvo

Corneal vascularization

D1 D31

8/8 dogs – 10/10 cats 2/8 dogs – 3/10 cats

Page 15: Cross linking dogs_cats_famose_ecvo

Corneal vascularization

D1 D31

8/8 dogs – 10/10 cats 2/8 dogs – 3/10 cats

Page 16: Cross linking dogs_cats_famose_ecvo

Corneal scar

D1 D31

8/8 dogs – 10/10 cats

Page 17: Cross linking dogs_cats_famose_ecvo

Corneal scar

D1 D31

8/8 dogs – 10/10 cats

Page 18: Cross linking dogs_cats_famose_ecvo

Discussion

Reduction of clinicaland pain score

UV light - Free radicals ?

Physical modifications of the cornea

Biological responses of the cornea ?

No Control Group

Page 19: Cross linking dogs_cats_famose_ecvo

Standard or accelerated protocol ?

Standard3 mW/cm²30 minutes

« Flash »30 mW/cm²3 minutes

5,4 J/cm²

Total durationabout 1h20

Total durationabout 40 min

Samebiologicaleffects ?

Same energydelivered

Page 20: Cross linking dogs_cats_famose_ecvo

Adverse reactions

Infections

Herpesvirus reactivation

Endothelial damage

In humans

No adverse reaction attributableto the treatment

Page 21: Cross linking dogs_cats_famose_ecvo

Conclusion

Efficacy

No adverse reaction

Shorteranesthesia

duration

Page 22: Cross linking dogs_cats_famose_ecvo

Impending perforation ?

Page 23: Cross linking dogs_cats_famose_ecvo

5,4J/cm²

Page 24: Cross linking dogs_cats_famose_ecvo

Are antibioticsstill necessary after CXL?

Page 25: Cross linking dogs_cats_famose_ecvo

Long term ? Corneal sensitivity ?Drug penetration ?

Normal cat

3 monthsPost CXL

Page 26: Cross linking dogs_cats_famose_ecvo

Thank you.